Latham & Watkins advises Ascendis Pharma A/S in US$150 million royalty funding agreement with Royalty Pharma

The Sponsor

Loading page...

Latham & Watkins advises Ascendis Pharma A/S in US$150 million royalty funding agreement with Royalty Pharma | The Sponsor - The Sponsor